London-based medical technology company Skin Analytics has been awarded Small Business Research Initiative (SBRI) Cancer Programme funding to scale use in the NHS of its AI technology that detects skin cancer. The AI tool, DERM, analyses skin lesions to help doctors find cancers at an early stage. Already in use by several NHS trusts including Royal Free NHS Foundation Trust, the highly accurate AI has helped over 38,000 NHS patients and detected more than 2,200 cancer cases to date. This new funding will support Skin Analytics and NHS services to open three new skin cancer pathways across England, accessible via community hubs, meaning that thousands more patients will have access to the world-leading DERM skin cancer pathway later this year. Neil Daly, founder and CEO of Skin Analytics, said: "By providing communities with faster and more convenient access to skin cancer assessments, our technology will help to improve outcomes for those diagnosed with cancer and for NHS teams.�